SU-GG-T-455: Experimental Evaluation of Irradiated Dose in Clinical Practice for Proton Therapy

2010 ◽  
Vol 37 (6Part23) ◽  
pp. 3291-3291
Author(s):  
T Matsuura ◽  
K Hotta ◽  
R Kohno ◽  
T Nishio ◽  
S Kameoka ◽  
...  
2007 ◽  
Vol 25 (8) ◽  
pp. 965-970 ◽  
Author(s):  
Michael Brada ◽  
Madelon Pijls-Johannesma ◽  
Dirk De Ruysscher

2012 ◽  
Vol 39 (7Part1) ◽  
pp. 4104-4114 ◽  
Author(s):  
Yusuke Egashira ◽  
Teiji Nishio ◽  
Taeko Matsuura ◽  
Satoru Kameoka ◽  
Mitsuru Uesaka

2011 ◽  
Vol 30 (5) ◽  
pp. 315-326 ◽  
Author(s):  
Hui Liu ◽  
Joe Y. Chang

Author(s):  
Chankyu Kim ◽  
Yeon‐Joo Kim ◽  
Nuri Lee ◽  
Sang Hee Ahn ◽  
Kwang Hyeon Kim ◽  
...  

2019 ◽  
Vol 127 ◽  
pp. 106145
Author(s):  
Hui-Yu Tsai ◽  
Hsin-Yu Chen ◽  
Ming-Wei Lee ◽  
Ze Wang ◽  
Sheng-Pin Tseng ◽  
...  

2012 ◽  
Vol 103 ◽  
pp. S23-S24
Author(s):  
J. Smeets ◽  
F. Roellinghoff ◽  
D. Prieels ◽  
F. Stichelbaut ◽  
A. Benilov ◽  
...  

2021 ◽  
Vol 8 (1) ◽  
pp. 354-365
Author(s):  
Johannes A. Langendijk ◽  
Frank J. P. Hoebers ◽  
Martin A. de Jong ◽  
Patricia Doornaert ◽  
Chris H. J. Terhaard ◽  
...  

Abstract In the Netherlands, the model-based approach is used to identify patients with head and neck cancer who may benefit most from proton therapy in terms of prevention of late radiation-induced side effects in comparison with photon therapy. To this purpose, a National Indication Protocol Proton therapy for Head and Neck Cancer patients (NIPP-HNC) was developed, which has been approved by the health care authorities. When patients qualify according to the guidelines of the NIPP-HNC, proton therapy is fully reimbursed. This article describes the procedures that were followed to develop this NIPP-HNC and provides all necessary information to introduce model-based selection for patients with head and neck cancer into routine clinical practice.


Sign in / Sign up

Export Citation Format

Share Document